Recent research has shown that most individuals with secondary lymphedema can safely engage in aerobic, resistive, and flexibility type exercises during Complete Decongestive Therapy (CDT) phase 2; however, adherence to exercise remains low for this population. Since lymphedema is a chronic disorder, strict adherence to CDT phase 2, or self-management of symptoms, is necessary. In general, it a...

BACKGROUND Fibrosis can enhance the exacerbation of lymphedema, which becomes obvious in late stage II-III lymphedema. However, whether far-infrared radiation thermotherapy (FIRT) can cure lymphedema fibrosis is still lack of research. This research was to investigate the therapeutic effect of FIRT on tissue fibrosis in the treatment of Late stage II-III lymphedema. METHODS Patients accepted ...

The concentration of cholesterol, apolipoproteins A-I, B, and E has been determined in lymphedema fluid from nine patients with chronic primary lymphedema. The concentrations were: 38.14 +/- 21.06 mg/dl for cholesterol, 15.6 +/- 6.17 mg/dl for apolipoprotein A-I, 7.5 +/- 2.8 mg/dl for apolipoprotein B, and 1.87 +/- 0.50 mg/dl for apolipoprotein E. These values represent 23%, 12%, 6%, and 38% of...

BACKGROUND Innovation in the treatment of lower extremity lymphedema has received low priority from the governments and pharmaceutical industry. Advancing lymphedema is irreversible and initiates fibrosis in the dermis, reactive changes in the epidermis and subcutis. Most medical treatments offered for lymphedema are either too demanding with a less than satisfactory response or patients have l...

BACKGROUND Imaging of the lymphatic system is difficult because of its structural and anatomical characteristics, and the conventional diagnostic method, radionuclide-based imaging, has the disadvantage of poor resolution. Magnetic resonance (MR) imaging has been shown the capability of depicting lymphatic channels in lymphedema recently. The purpose of this study was to evaluate the imaging of...

BACKGROUND Lymphedema of the leg and its advanced form, known as elephantiasis, are significant causes of disability and morbidity in areas endemic for lymphatic filariasis (LF), with an estimated 14 million persons affected worldwide. The twin goals of the World Health Organization's Global Program to Eliminate Lymphatic Filariasis include interrupting transmission of the parasitic worms that ...

Recent research has shown that most individuals with secondary lymphedema can safely engage in aerobic, resistive, and flexibility type exercises during Complete Decongestive Therapy (CDT) phase 2; however, adherence to exercise remains low for this population. Since lymphedema is a chronic disorder, strict adherence to CDT phase 2, or self-management of symptoms, is necessary. In general, it a...

IMPORTANCE The prevalence and clinical burden of lymphedema is known to be increasing. Nevertheless, evidence-based comparative effectiveness data regarding lymphedema therapeutic interventions have been poor. OBJECTIVE To examine the impact of an advanced pneumatic compression device (APCD) on cutaneous and other clinical outcomes and health economic costs in a representative privately insur...

Objective: Lymphedema on affected side of upper limb is one of the most common complications after breast cancer surgery. This paper intends to discuss the morbidity of limb lymphedema and analyzes related risk factors, in hope of providing some guidance for early prevention of such complication. Method: 2,597 female patients with breast cancer who received operations in our hospital from Decem...

OBJECTIVE To identify the effect of decongestive lymphedema treatment on excess arm volume or patient-centered outcomes in women presenting within either 12 months or a mean nine months of developing arm lymphedema following breast cancer treatment. INTRODUCTION Lymphedema is a common consequence of breast cancer treatment requiring life-long treatment to reduce symptoms and prevent complicat...